Clinical trial
A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
NCT03528369 is registered in ClinicalTrials.gov with Propella Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
- Lead sponsor
- Propella Therapeutics
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 14, 2018
- Completion date
- December 30, 2018
- Enrollment
- 122 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.